
Sign up to save your podcasts
Or
In this interview, Steven E. Nissen, MD, MACC and Anthony N. DeMaria MD, MACC, with Anum Saeed MD, discuss the ACC.22 Late Breaker: Magnitude and Duration of Effects of a Short-interfering RNA Targeting Lipoprotein(a): A Placebo-controlled Double-blind Dose-ranging Trial.
3.7
5353 ratings
In this interview, Steven E. Nissen, MD, MACC and Anthony N. DeMaria MD, MACC, with Anum Saeed MD, discuss the ACC.22 Late Breaker: Magnitude and Duration of Effects of a Short-interfering RNA Targeting Lipoprotein(a): A Placebo-controlled Double-blind Dose-ranging Trial.
131 Listeners
323 Listeners
160 Listeners
863 Listeners
494 Listeners
274 Listeners
3,319 Listeners
87 Listeners
135 Listeners
1,084 Listeners
39 Listeners
186 Listeners
351 Listeners
423 Listeners
34 Listeners